Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sangamo Therapeutics (SGMO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 1,149,638
  • Shares Outstanding, K 83,610
  • Annual Sales, $ 19,390 K
  • Annual Income, $ -71,660 K
  • 36-Month Beta 3.15
  • Price/Sales 61.67
  • Price/Cash Flow 0.00
  • Price/Book 5.30

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.10 +36.14%
on 08/23/17
15.05 -8.64%
on 09/01/17
+3.50 (+34.15%)
since 08/22/17
3-Month
8.00 +71.88%
on 08/01/17
15.05 -8.64%
on 09/01/17
+4.55 (+49.46%)
since 06/22/17
52-Week
2.65 +418.87%
on 12/08/16
15.05 -8.64%
on 09/01/17
+8.93 (+185.27%)
since 09/22/16

Most Recent Stories

More News
Sangamo Therapeutics Announces Presentation At The 2017 Cantor Fitzgerald Global Healthcare Conference

Sangamo Therapeutics, Inc. (Nasdaq: SGMO) announced today that Sandy Macrae, M.B., Ch.B., Ph.D., Sangamo's chief executive officer, will present at the 2017 Cantor Fitzgerald Global Healthcare Conference...

SGMO : 13.75 (-3.85%)
4 Biotech Stocks That Show Promise on Sustainable Growth

Biotech sector is performing well in 2017 due to an increase in FDA approvals, new product sales ramp up, R&D success and innovation, strong clinical study results and continued strong performance of legacy...

SGMO : 13.75 (-3.85%)
HSKA : 89.36 (-0.13%)
CORT : 18.20 (+3.94%)
LLY : 83.91 (+0.70%)
HLUYY : 60.1180 (+2.89%)
GILD : 83.27 (+0.79%)
KITE : 179.30 (-0.04%)
ALXN : 142.82 (-0.07%)
The Zacks Analyst Blog Highlights: Caladrius Biosciences, Orexigen Therapeutics, Sangamo Therapeutics and Syndax Pharmaceuticals

The Zacks Analyst Blog Highlights: Caladrius Biosciences, Orexigen Therapeutics, Sangamo Therapeutics and Syndax Pharmaceuticals

SGMO : 13.75 (-3.85%)
OREX : 2.12 (-7.22%)
CLBS : 3.80 (+0.26%)
SNDX : 11.35 (-0.53%)
Why These 4 Biotech Stocks May Not Lose Momentum Soon

The biotech industry has shown strength so far this year. The momentum is likely to continue for some time, it's a good idea to pick a few stocks that are unlikely to lose their momentum soon.

SGMO : 13.75 (-3.85%)
OREX : 2.12 (-7.22%)
CLBS : 3.80 (+0.26%)
SNDX : 11.35 (-0.53%)
5 Top-Ranked Biotech Stocks to Buy Right Now

If you are looking to invest in the biotech sector, here is a peek at 5 buy-ranked biotech stocks including Regeneron Pharmaceuticals (REGN).

SGMO : 13.75 (-3.85%)
LGND : 135.55 (-0.19%)
GILD : 83.27 (+0.79%)
REGN : 432.72 (-0.17%)
KITE : 179.30 (-0.04%)
FATE : 4.12 (+4.57%)
ALXN : 142.82 (-0.07%)
Sangamo Presents T Cell Engineering Capabilities at Immuno-Oncology Summit

Sangamo Therapeutics (Nasdaq: SGMO) this afternoon is presenting preclinical data demonstrating the Company's engineering capabilities in T cell genome editing using zinc finger nucleases (ZFNs). Gary...

SGMO : 13.75 (-3.85%)
Sangamo Therapeutics Announces Presentations At Upcoming Investor Conferences

Sangamo Therapeutics, Inc. (Nasdaq: SGMO) announced today that members of the Company's senior management team are scheduled to participate in the following healthcare investor conferences in September....

SGMO : 13.75 (-3.85%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Juno Therapeutic (JUNO, IMGN, SGMO, PBYI, BLCM)

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

SGMO : 13.75 (-3.85%)
PBYI : 104.50 (-0.29%)
IMGN : 6.55 (+0.77%)
BLCM : 11.41 (+1.06%)
JUNO : 45.14 (+8.46%)
Sangamo Therapeu Has Returned 92.1% Since SmarTrend Recommendation (SGMO)

SmarTrend identified an Uptrend for Sangamo Therapeu (NASDAQ:SGMO) on May 11th, 2017 at $6.65. In approximately 4 months, Sangamo Therapeu has returned 92.11% as of today's recent price of $12.78.

SGMO : 13.75 (-3.85%)
Watch for Sangamo Therapeu to Potentially Pullback After Gaining 11.30% Yesterday

Sangamo Therapeu (NASDAQ:SGMO) traded in a range yesterday that spanned from a low of $11.15 to a high of $12.90. Yesterday, the shares gained 11.3%, which took the trading range above the 3-day high...

SGMO : 13.75 (-3.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc.,...

See More

Support & Resistance

2nd Resistance Point 14.68
1st Resistance Point 14.22
Last Price 13.75
1st Support Level 13.47
2nd Support Level 13.18

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.